Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
2.490
-0.070 (-2.73%)
At close: Dec 5, 2025, 4:00 PM EST
2.480
-0.010 (-0.40%)
After-hours: Dec 5, 2025, 7:57 PM EST
Whitehawk Therapeutics Employees
Whitehawk Therapeutics had 40 employees as of December 31, 2024. The number of employees decreased by 49 or -55.06% compared to the previous year.
Employees
40
Change (1Y)
-49
Growth (1Y)
-55.06%
Revenue / Employee
$359,600
Profits / Employee
-$390,450
Market Cap
117.35M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 40 | -49 | -55.06% |
| Dec 31, 2023 | 89 | 10 | 12.66% |
| Dec 31, 2022 | 79 | 40 | 102.56% |
| Dec 31, 2021 | 39 | 31 | 387.50% |
| Dec 31, 2020 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
WHWK News
- 5 days ago - Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer - PRNewsWire
- 10 days ago - Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - PRNewsWire
- 25 days ago - Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London - PRNewsWire
- 4 weeks ago - Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights - PRNewsWire
- 6 weeks ago - Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC - PRNewsWire
- 7 weeks ago - Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research - Business Wire
- 3 months ago - Whitehawk Therapeutics, Inc. (WHWK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 3 months ago - Whitehawk Therapeutics to Participate in Upcoming Investor Conferences - PRNewsWire